2
Table of Contents
NLA Dyslipidemia – Part II represents a continuation of NLA Dyslipidemia – Part I
providing patient-centered, evidence-graded recommendations for the management of
specific aspects of dyslipidemia.
ese categories are listed in the Table of Contents below.
Page
4
Key Points
5
Table 1. Criteria for ASCVD Risk Assessment,
Treatment Goals for Atherogenic Cholesterol, and
Levels at Which to Consider Drug Therapy
7-12
Lifestyle
7
Chart 1. Nutritional Recommendations
10
Table 2. Changes from Baseline Lipoprotein Lipid
Levels by Diet in Omniheart
10
Table 3. Predicted Effects of Macronutrient
Replacement of Dietary Saturated Fatty
Acids with PUFA, MUFA, and Carbohydrate
on Lipoprotein Lipids Based on Results from
Controlled Feeding Trials
10
Chart 2. Exercise/Physical Activity
Recommendations
11
General Management
11
Chart 3. Patient Adherence
11
Chart 4. Team-Based Collaborative Care
12-14
Hypertriglyceridemia
12
Table 4. Evaluation of Hypertriglyceridemia
13
Figure 1. Clinical Algorithm for Screening and
Management of Elevated TG
